Baltimore biotech WindMIL Therapeutics raises $32.5 million
June 18, 2018 at 07:30 AM EDT
The clinical stage cell therapy company is previously backed by about $11 million in funding.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.